Introduction
Killed influenza vaccines currently in use contain either whole virions or a mixture of antigens obtained by disrupting the virus particles with detergents or organic solvents (Perkins and Regamey, 1973;  Perkins, Regamey and Hennessen, 1975) .
It is well established that antibodies against two of the viral proteins, haemagglutinin and neuraminidase, give optimal protection against influenza (Dowdle et al., 1973) . None of the other viral proteins, which are located beneath a host-derived lipid membrane, is essential for immunity. An ideal influenza vaccine should, therefore, contain only these two essential immunogens, since the other protein and lipid antigens may cause undesired side reactions.
All methods for the preparation of purified influenza immunogens ('subunits') described so far utilize as a first step a more or less complete disruption of the virus particle (Laver, 1973) . Thus, these * Present address: Sandoz AG Nuirnberg, GFR.
Correspondence: Dr Helmut Bachmayer, Sandoz Forschungsinstitut, Brunnerstrasse 59, A-1235 Wien, Austria. procedures set free all the components, namely proteins, lipids and nucleic acids, of the virion.
A different approach was utilized in this study. The possibility was investigated of selectively solubilizing the haemagglutinin and neuraminidase from the virus particle. The pronounced difference in size and density of the components would allow the use of simple separation procedures.
This approach of 'selective' solubilization, as contrasted to 'complete' solubilization, is illustrated in Fig. 1 .
Materials and methods

Viruses
Egg-grown viruses purified by zonal ultracentrifugation were used throughout these studies. The prototype strains were obtained from G. C. Schild (WHO World Influenza Centre, London).
Animal studies
Immunization schedule: Equal doses of vaccines (approx. 1400 i.u./ml A/Port Chalmers/73 whole virus and subunits) given on day 0 and day 28, blood samples drawn on day 28 and day 35. Route of immunization: i.p. for mice and hamsters, s.c. for guinea-pigs, s.c. and i.m. for rabbits.
Some of the vaccines studied contained 0-1500 Al(OH)3 as adjuvant.
For protection experiments thirty mice in each group were immunized (0 25 ml i.p.) with vaccines containing influenza A/Hong Kong/68 (X-31 recombinant, diluted to HA titres of 1: 32) in 0 2%4
Al(OH)3 as adjuvant. Animals were challenged with mice-adapted A/Hong Kong/68 virus (102.5 LD5O).
Further experimental details are either given in the legends to the figures or will be included in separate publications on the biochemical (Bachmayer, 1975) The fractions obtained were analysed for haemagglutinin and neuraminidase activities and their radioactivity determined.
The results obtained with different concentrations of the non-ionic detergent Neodol 23-6 (Shell) are illustrated in Fig. 2 . Panel (a) shows the untreated control sample: haemagglutinin, neuraminidase and 32P radioactivity are located in a single peak representing the whole virus position.
A change in the distribution of the biological activities and radioactivity can be observed in the experiments shown in panels (b), (c) and (d) However, the haemagglutinin and neuraminidase are highly aggregated and sediment almost as fast as the intact virus particle.
Results very similar to the ones just described are obtained when Neodol 23-6 is substituted by other non-ionic detergents or by anionic detergents such as sodium desoxycholate or sodium dodecyl sulphate. The haemagglutinin and the neuraminidase are either only partially released from the virus or-at higher detergent concentrations-the virus particle is further degraded as indicated by solubilization of 32P radioactivity.
In the course of our comparative studies with different groups of detergents, the use of cationic detergents was also investigated. The use of this group of surfactants for the solubilization of viral components has not been described so far. The results obtained on incubation of 32P-labelled influenza virus with different concentrations of hexadecyltrimethyl ammonium bromide (cetyl trimethyl ammonium bromide, CTAB) are given in Fig. 3 .
At the highest concentrations used, haemagglutinin and neuraminidase are solubilized together with 32P label (Fig. 3d) . The lowest concentration studied gives only partial release of haemagglutinin and neuraminidase, still highly aggregated (Fig. 3b) . So far, the results parallel the observations made with the other group of detergents as described before. tively. 0 ---0, Neuraminidase activity; @-@, HA log2; X--X 0-2CPMin 05 ml. (Bachmayer, 1975 (Bachmayer, 1975) . The intact state of the subviral particles was further confirmed by electron microscopy (Fig. 4) A standardized set of subunit vaccine and whole virus used for the production of it was directly compared in all these experiments.
The primary (day 28) and secondary (day 35) immune response to influenza A/Port Chalmers was studied in rabbits, hamsters, guinea-pigs and mice (Tables 1-4 ). Observed differences in the antibody response of the animal species studied are pronounced. The best response both with whole virus and subunit vaccine was observed in guinea-pigs (Table 3) . In this animal model the subunit vaccine was equal or even superior to the whole virus vaccine. However, the secondary immune response stimulated by application of the subunit vaccine seems to exceed the response to the whole virus in the other animal species as well. From the data it can also be concluded that the responses to haemagglutinin and neuraminidase antigens do not necessarily go parallel.
The results of mice protection experiments performed with influenza A/Hong Kong/68 are shown in Fig. 6 . Animals immunized with whole virus and subunit vaccines, respectively, were infected with mice adapted virus 3, 4 and 8 weeks after immunization. Protection rates were calculated from the degree of lung lesions scored at day 9 after challenge. Different kinetics were found for the protection conferred to the animals immunized with whole virus and subunits respectively. At week 4 or later the subunit vaccine seems to be at least equal to the whole virus vaccine.
To evaluate the immunogenicity of this novel type (Krag and Bentzon, 1971) . Solubilized immunogens were prepared from half of this virus concentrate as outlined above. Adjuvant (0-15% Al(OH)3) was added to part of the whole virus and subunit preparations. The antigen content of these four vaccines (whole virus fluid, whole virus with adjuvant, subunit fluid, subunit with adjuvant) was again tested using the recently described single radial immunodiffusion technique (Schild, Wood and Newman, 1975) (Fig. 7) .
Three of the vaccines were found to contain an equal antigen content of 1557 i.u./ml. With the adjuvant containing subunit vaccine only 65/o of the haemagglutinin content originally present could be found in the test. This would indicate that solubilized haemagglutinin and neuraminidase are much stronger absorbed to Al(OH)3 than whole virus particles.
The field trial was performed in a double blind manner. Volunteers (forty-eight to sixty-five persons per group) received one of the four vaccines by random allocation. Blood samples were taken on the day of vaccination, 4 and 12 weeks later. Antibodies against haemagglutinin and neuraminidase were determined using standard methods. The distribution of haemagglutinin and neuraminidase inhibiting antibodies observed on day 0, 28 and 90 after vaccination is shown in Fig. 8 (HI) and Fig. 9 observed in the titre distributions obtained after application of the whole virus or subunit vaccines. It is interesting to note that the adjuvant in the vaccines did not increase the level or duration of antibody titres (Kunz and Hofmann, 1975) . The serological findings are summarized in numerical form in Table 5 . Geometric mean titres (haemagglutinin and neuraminidase inhibition) are listed together with the levels of protective antibody (HItitres > 1: 64) on day 0, 28 and 90. According to all these criteria the subunit vaccine was found to be at least as effective as the standardized whole virus vaccine used for comparison.
Questionnaires were used to determine the degree of side reactions observed by the volunteers. A significantly lower number of side reactions was found after application of the subunit vaccine without adjuvant, as compared with any of the other formulations tested (Kunz and Hofmann, 1975 ). (Kunz and Hofmann, 1975) . *-, Day O; * ------, day 28.
